These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery. Pinheiro JM, Santana-Rivas Q, Pezzano C. J Perinatol; 2016 Mar; 36(3):196-201. PubMed ID: 26633145 [Abstract] [Full Text] [Related]
23. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study. Jeon GW, Oh M, Sin JB. Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992 [Abstract] [Full Text] [Related]
30. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR, Malloy MH, Brown DR, Holzman IR, Coghill CH, Carlo WA, Pramanik AK, McCaffree MA, Toubas PL, Laudert S, Gratny LL, Weatherstone KB, Seguin JH, Willett LD, Gutcher GR, Mueller DH, Topper WH. Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357 [Abstract] [Full Text] [Related]
31. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Fujiwara T, Konishi M, Chida S, Okuyama K, Ogawa Y, Takeuchi Y, Nishida H, Kito H, Fujimura M, Nakamura H. Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230 [Abstract] [Full Text] [Related]
32. Early treatment of respiratory distress syndrome with bovine surfactant in very preterm infants: a multicenter controlled clinical trial. Gortner L, Bartmann P, Pohlandt F, Bernsau U, Porz F, Hellwege HH, Seitz RC, Hieronimi G, Bremer C, Jorch G. Pediatr Pulmonol; 1992 Sep; 14(1):4-9. PubMed ID: 1437342 [Abstract] [Full Text] [Related]
33. A pilot, randomized, controlled clinical trial of lucinactant, a peptide-containing synthetic surfactant, in infants with acute hypoxemic respiratory failure. Thomas NJ, Guardia CG, Moya FR, Cheifetz IM, Markovitz B, Cruces P, Barton P, Segal R, Simmons P, Randolph AG, PALISI Network. Pediatr Crit Care Med; 2012 Nov; 13(6):646-53. PubMed ID: 22791092 [Abstract] [Full Text] [Related]
36. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480 [Abstract] [Full Text] [Related]
37. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. Horbar JD, Soll RF, Sutherland JM, Kotagal U, Philip AG, Kessler DL, Little GA, Edwards WH, Vidyasagar D, Raju TN. N Engl J Med; 1989 Apr 13; 320(15):959-65. PubMed ID: 2648150 [Abstract] [Full Text] [Related]
38. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Egberts J, de Winter JP, Sedin G, de Kleine MJ, Broberger U, van Bel F, Curstedt T, Robertson B. Pediatrics; 1993 Dec 13; 92(6):768-74. PubMed ID: 8233735 [Abstract] [Full Text] [Related]